Contract 75A50119C00037

Emergent Biosolutions Canada Inc · Department Of Health And Human Services · June 30, 2025

Firm Fixed PriceSole SourceNAICS 325412

Emergent Biosolutions Canada Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on June 30, 2025 for $105.65 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 23, 2026. If all options are exercised, the contract could reach $706.47 million.

Obligated to date
$105.65M
$105,648,130
Current value
$422.32M
Potential value
$706.47M
if all options exercised
Modifications
2
Latest March 23, 2026

Contract details

PIID
75A50119C00037
Award type
Definitive Contract
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Not Competed
NAICS
325412 · Pharmaceutical Preparation Manufacturing
Product / service
Drugs And Biologicals
First action
June 30, 2025
Latest action
March 23, 2026

Description

VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATES SERVICES FOR UP TO 10 YEARS.

Modification timeline

  • March 23, 2026
    Mod P00017 · Exercise An Option
    $422.32M
  • July 2, 2025
    Mod P00016 · Exercise An Option
    $368.58M
  • June 30, 2025
    Mod P00015 · Change Order
    VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
    $316.67M

Similar contracts

RecipientAgencyDateObligated
Astrazeneca Pharmaceuticals LpDepartment Of Health And Human ServicesMarch 31, 2026$122.8K
Four Points Technology, L.L.C.Department Of Health And Human ServicesMarch 31, 2026$246.6K
Ase Direct, Inc.Department Of Health And Human ServicesMarch 30, 2026$49.0K
Emergent Biosolutions Canada IncDepartment Of Health And Human ServicesMarch 30, 2026$256.40M
Mckesson CorporationDepartment Of Health And Human ServicesMarch 30, 2026$9.00M
Sanofi Vaccines Us Inc.Department Of Health And Human ServicesMarch 27, 2026$92.33M

Top contractors in NAICS 325412

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Mckesson Corporation1,187$4.96B
2Merck Sharp & Dohme Llc26$894.71M
3Sanofi Vaccines Us Inc.57$702.38M
4Pfizer Inc169$541.15M
5Glaxosmithkline, Llc14$505.04M
6Phlow Corp.1$105.27M
7Exelan Pharmaceuticals Inc76$104.30M
8Seqirus USA Inc47$59.15M
9Emergent Biosolutions Canada Inc2$53.73M
10Mckesson Specialty Distribution Llc1$51.05M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75A50119C00037?

Contract 75A50119C00037 is a federal contract awarded to Emergent Biosolutions Canada Inc by Department Of Health And Human Services on June 30, 2025 for $105.65 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.

Who won contract 75A50119C00037?

Emergent Biosolutions Canada Inc won contract 75A50119C00037 from Department Of Health And Human Services.

How much is contract 75A50119C00037 worth?

Contract 75A50119C00037 has obligated $105.65 million to date, with a total potential value of $706.47 million if all options are exercised.